30 Years of Experience in the Management of Stage III and IV Epithelial Ovarian Cancer: Impact of Surgical Strategies on Survival

by Berenice Delga, Jean-Marc Classe, Gilles Houvenaeghel, Guillaume Blache, Laura Sabiani, Houssein El Hajj, Nicole Andrieux, Eric Lambaudie
Published 2020-03-01

Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients

by Camille Moreau-Bachelard, Loïc Campion, Marie Robert, Olivier Kerdraon, Céline Renaudeau, Maud Aumont, Jean-Marc Classe, Mario Campone, Jean-Sébastien Frénel
Published 2020-12-01

NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment.

by Nassima Redjimi, Karine Duperrier-Amouriaux, Isabelle Raimbaud, Immanuel Luescher, Danijel Dojcinovic, Jean-Marc Classe, Dominique Berton-Rigaud, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, Danila Valmori, Maha Ayyoub
Published 2011-01-01

Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.

by Ahmed Hamaï, Karine Duperrier-Amouriaux, Pascale Pignon, Isabelle Raimbaud, Lorenzo Memeo, Cristina Colarossi, Vincenzo Canzonieri, Tiziana Perin, Jean-Marc Classe, Mario Campone, Pascal Jézéquel, Loïc Campion, Maha Ayyoub, Danila Valmori
Published 2011-01-01

Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?

by Fabien Vidal, Paul Guerby, Mathieu Luyckx, Pascale Haddad, Eberhard Stoeckle, Philippe Morice, Eric Leblanc, Fabrice Lecuru, Emile Daraï, Jean Marc Classe, Christophe Pomel, Thomas Filleron, Gwenael Ferron, Denis Querleu, Arash Rafii
Published 2016-01-01

Lymph node positivity in different early breast carcinoma phenotypes: a predictive model

by Gilles Houvenaeghel, Eric Lambaudie, Jean-Marc Classe, Chafika Mazouni, Sylvia Giard, Monique Cohen, Christelle Faure, Hélène Charitansky, Roman Rouzier, Emile Daraï, Delphine Hudry, Pierre Azuar, Richard Villet, Pierre Gimbergues, Christine Tunon de Lara, Marc Martino, Jean Fraisse, François Dravet, Marie Pierre Chauvet, Jean Marie Boher
Published 2019-01-01

Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowle...

by Maggie Banys-Paluchowski, Maria Luisa Gasparri, Jana de de Boniface, Oreste Gentilini, Elmar Stickeler, Steffi Hartmann, Marc Thill, Isabel T. Rubio, Rosa Di Di Micco, Eduard-Alexandru Bonci, Laura Niinikoski, Michalis Kontos, Guldeniz Karadeniz Karadeniz Cakmak, Michael Hauptmann, Florentia Peintinger, David Pinto, Zoltan Matrai, Dawid Murawa, Geeta Kadayaprath, Lukas Dostalek, Helidon Nina, Petr Krivorotko, Jean-Marc Classe, Ellen Schlichting, Matilda Appelgren, Peter Paluchowski, Christine Solbach, Jens-Uwe Blohmer, Thorsten Kühn, the AXSANA Study Group
Published 2021-03-01

Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’

by Suzy Scholl, Marina Popovic, Anne de la Rochefordiere, Elodie Girard, Sylvain Dureau, Aljosa Mandic, Katarina Koprivsek, Nina Samet, Marius Craina, Madalin Margan, Sanne Samuels, Henry Zijlmans, Gemma Kenter, Peter Hillemanns, Sorin Dema, Alis Dema, Goran Malenkovic, Branislav Djuran, Anne Floquet, Delphine Garbay, Frédéric Guyon, Pierre Emmanuel Colombo, Michel Fabbro, Christine Kerr, Charlotte Ngo, Fabrice Lecuru, Eleonor Rivin del Campo, Charles Coutant, Frédéric Marchal, Nathalie Mesgouez-Nebout, Virginie Fourchotte, Jean Guillaume Feron, Philippe Morice, Eric Deutsch, Pauline Wimberger, Jean-Marc Classe, Noreen Gleeson, Heiko von der Leyen, Mathieu Minsat, Coraline Dubot, Pierre Gestraud, Attila Kereszt, Istvan Nagy, Balazs Balint, Els Berns, Ekaterina Jordanova, Nicolas de Saint-Jorre, Alexia Savignoni, Nicolas Servant, Philippe Hupe, Leanne de Koning, Pierre Fumoleau, Roman Rouzier, Maud Kamal
Published 2020-07-01

Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcomeResearch in context

by Suzy Scholl, Marina Popovic, Anne de la Rochefordiere, Elodie Girard, Sylvain Dureau, Aljosa Mandic, Katarina Koprivsek, Nina Samet, Marius Craina, Madalin Margan, Sanne Samuels, Henry Zijlmans, Gemma Kenter, Peter Hillemanns, Sorin Dema, Alis Dema, Goran Malenkovic, Branislav Djuran, Anne Floquet, Delphine Garbay, Frédéric Guyon, Pierre Emmanuel Colombo, Michel Fabbro, Christine Kerr, Charlotte Ngo, Fabrice Lecuru, Eleonor Rivin del Campo, Charles Coutant, Frédéric Marchal, Nathalie Mesgouez-Nebout, Virginie Fourchotte, Jean Guillaume Feron, Philippe Morice, Eric Deutsch, Pauline Wimberger, Jean-Marc Classe, Noreen Gleeson, Heiko von der Leyen, Mathieu Minsat, Coraline Dubot, Pierre Gestraud, Attila Kereszt, Istvan Nagy, Balazs Balint, Els Berns, Ekaterina Jordanova, Nicolas de Saint-Jorre, Alexia Savignoni, Nicolas Servant, Philippe Hupe, Leanne de Koning, Pierre Fumoleau, Roman Rouzier, Maud Kamal
Published 2019-05-01